• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals


22.8100 USD 0.1000 0.44%

As of 20:10:00 ET on 04/17/2014.

Snapshot for Akorn Inc (AKRX)

Open: 22.7500 Day's Range: 22.2810 - 23.1600 Volume: 674,475
Previous Close: 22.7100 52wk Range: 12.8550 - 28.0000 1-Yr Rtn: +61.66%

Stock Chart for AKRX

No chart data available.
  • AKRX:US 22.8100
  • 1D
  • 1M
  • 1Y
Interactive AKRX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AKRX

Current P/E Ratio (ttm) 50.2760
Estimated P/E(12/2014) 27.5816
Relative P/E vs. SPX 2.9235
Earnings Per Share (USD) (ttm) 0.4537
Est. EPS (USD) (12/2014) 0.8270
Est. PEG Ratio 1.1958
Market Cap (M USD) 2,204.67
Shares Outstanding (M) 96.65
30 Day Average Volume 928,268
Price/Book (mrq) 8.4662
Price/Sale (ttm) 6.9058
Dividend Indicated Gross Yield -%
Cash Dividend (USD) -
Dividend Ex-Date 08/29/1991
5 Year Dividend Growth -
Next Earnings Announcement 05/06/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AKRX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AKRX

Akorn, Inc. develops, manufactures, and markets ophthalmic and injectable pharmaceutical products. The Company sells various diagnostic and therapeutic pharmaceutical products focused primarily on ophthalmology, anesthesia, antidotes, and rheumatology. Akorn also markets ophthalmic surgical instruments and other supplies, and provides contract manufacturing for third parties.

Rajat Rai "Raj"Chief Executive OfficerTimothy A Dick "Tom"CFO/Investor Relations
Bruce KutinskyChief Operating OfficerMark M SilverbergExec VP: Quality Assurance
More Company Profile & Key Executives for AKRX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil